Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Makenzie L Fulmer"'
Autor:
Victoria M. Pratt, Larisa H. Cavallari, Makenzie L. Fulmer, Andrea Gaedigk, Houda Hachad, Yuan Ji, Lisa V. Kalman, Reynold C. Ly, Ann M. Moyer, Stuart A. Scott, R.H.N. van Schaik, Michelle Whirl-Carrillo, Karen E. Weck
Publikováno v:
The Journal of molecular diagnostics : JMD, 24(10), 1051-1063. Elsevier Inc.
The goals of the Association for Molecular Pathology Clinical Practice Committee's Pharmacogenomics (PGx) Working Group are to define the key attributes of pharmacogenetic alleles recommended for clinical testing and a minimum set of variants that sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266e61f6e073bae1c479a3a9fcefe7a2
https://pure.eur.nl/en/publications/0c57d93a-8856-4864-afdf-283c0a8c7453
https://pure.eur.nl/en/publications/0c57d93a-8856-4864-afdf-283c0a8c7453
Autor:
Rebecca L. Margraf, Rachel Z. Alexander, Makenzie L. Fulmer, Christine E. Miller, Elena Coupal, Rong Mao
Publikováno v:
Human mutationREFERENCES.
The Multiple Endocrine Neoplasia type 2 (MEN2) RET proto-oncogene database, originally published in 2008, is a comprehensive repository of all publicly available RET gene variations associated with MEN2 syndromes. The variant-specific genotype/phenot
Autor:
Rebecca L. Margraf, Rachel Z. Alexander, Makenzie L. Fulmer, Christine Miller, Elena Coupal, Rong Mao
The Multiple Endocrine Neoplasia type 2 (MEN2) RET proto-oncogene database, originally published in 2008, is a comprehensive repository of all publicly available RET gene variations associated with MEN2 syndromes. The variant-specific genotype/phenot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d683596aabc8f91ab68e99f14fa0e055
https://doi.org/10.22541/au.165053552.26865967/v1
https://doi.org/10.22541/au.165053552.26865967/v1
Publikováno v:
Cancer Genetics. :S6-S7
Publikováno v:
Journal of Cardiology and Therapeutics. 3:53-63
Purpose : WIN55,212-2, a potent synthetic agonist of cannabinoid receptor type 1 (CB1) and cannabinoid receptor type 2 (CB2), reduces atherosclerosis in apolipoprotein E (ApoE) null mice. Although pharmacologic evidence suggests the anti-atherosclero
Autor:
Makenzie L Fulmer, Douglas P. Thewke
Decades of research has provided evidence for the role of the endocannabinoid system in human health and disease. This versatile system, consisting of two receptors (CB1 and CB2), their endogenous ligands (endocannabinoids), and metabolic enzymes has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4979c8a1a9b066faff02507fe39e82d4
https://europepmc.org/articles/PMC6020134/
https://europepmc.org/articles/PMC6020134/
Publikováno v:
Current Human Cell Research and Applications ISBN: 9789811072956
The Met proto-oncogene encodes MET tyrosine kinase protein which is a receptor for hepatocyte growth factor/scatter factor (HGF/SF). HGF binds to and activates MET to regulate diversified cellular and molecular activities such as proliferation, motil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::216276a51c0e0fb056d3f91cf0a05cda
https://doi.org/10.1007/978-981-10-7296-3_8
https://doi.org/10.1007/978-981-10-7296-3_8
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 36
Background: Calcification of atherosclerotic plaques is associated with vulnerability to rupture and increased risk of myocardial infarction. The mechanism of plaque calcification is unclear, but has been shown to be a cell-mediated process involving
Publikováno v:
Journal of Biosafety & Health Education.
The alpha-gal epitope is distinctive in its dispersal in mammals; it is generously expressed in non-primate mammalian, New World monkeys, and prosimians, where by contrast an IgG antibody binding to this epitope is produced naturally in humans, Old W